Microfluidic capillary transit velocity as a functional measure for sickle cell disease and in vitro -derived red blood cells

Authors:

Abstract
This study presents a biomimetic microfluidic assay to evaluate the capillary transit velocity of red blood cells at single-cell resolution, highlighting heterogeneity and therapeutic effects in sickle cell disease and in vitro derived cells.
Funding Information
  • NIH Office of the Director (U01AI176469)
  • Fogarty International Center (D43TW012260)
  • National Heart, Lung, and Blood Institute (R41HL172662)
  • National Heart, Lung, and Blood Institute (R42HL162214)
  • National Heart, Lung, and Blood Institute (R44HL140739)
  • National Heart, Lung, and Blood Institute (R56HL165946)
  • National Center for Advancing Translational Sciences (UM1TR004528)
  • American Society of Hematology (Graduate Hematology Award)

This publication has 60 references indexed in Scilit: